02
Nov
#CurisLifesciencesIPO #PharmaIPO #NSEEmerge #SMEIPO #Pharmaceuticals #IndianMarkets #IPO2025 #HealthcareInvesting #CapitalMarkets #ContractManufacturing #GujaratBusiness #StockMarketIndia Chandigarh: Gujarat-based pharmaceutical company Curis Lifesciences is set to enter capital markets with its initial public offering (IPO) beginning November 7, 2025. The company plans to raise Rs 27.52 crore through a fresh issue of 21.5 lakh shares, priced between Rs 120 and Rs 128 per share. This issue is a 100% fresh issue, meaning no shares will be offered through an offer-for-sale by existing shareholders. The IPO subscription will remain open until November 11, with share allotment expected on November 12, and shares to be listed on…